C4 THERAPEUTICS, INC.

(CCCC)
  Report
Delayed Nasdaq  -  05/19 04:00:00 pm EDT
6.610 USD   +3.93%
05/16C4 THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/16C4 Therapeutics, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating CFT8634, an Orally Bioavailable BiDAC™ Degrader for the Treatment of Synovial Sarcoma and SMARCB1-Null Tumors
CI
05/16C4 Therapeutics Says First Patient Dosed in Early Trial of Cancer Drug
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Technical AnalysisHistorical ChartNews ChartSector ChartComparison ChartReversed ChartRelative Strength Chart
Reversed stock chart C4 Therapeutics, Inc.
Period : Moving averages : Log scale :